Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-15

FDA Approved: EZETIMIBE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves Ascend Laboratories, LLC's supplemental application for ezetimibe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

SUPPL AP for EZETIMIBE (EZETIMIBE)